Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|August 22, 2014
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemiaKenneth F Bradstock, Emma Link, Marnie Collins, et al.
Pathology|August 19, 2006
Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral bloodWilliam S Stevenson, Rosemary Hoyt, Anthony Bell, et al.
JAMA|April 29, 2010
Hematopoietic stem cell transplantation: a global perspectiveAlois Gratwohl, Helen Baldomero, Mahmoud Aljurf, et al.
The New England Journal of Medicine|April 23, 2020
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Nikolas von Bubnoff, Jason Butler, et al.
Internal Medicine Journal|October 17, 2018
Revisiting acquired aplastic anaemia: current concepts in diagnosis and managementDanielle B Clucas, Lucy C Fox, Erica M Wood, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 15, 2023
Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patientsMichelle Tew, Abby P Douglas, Jeff Szer, et al.
Haematologica|March 20, 2013
Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational StudyAlois Gratwohl, Helen Baldomero, Michael Gratwohl, et al.
Australian Health Review : a Publication of the Australian Hospital Association|December 1, 2011
A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatmentSenthil Lingaratnam, Leon J Worth, Monica A Slavin, et al.
Blood|July 20, 2002
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemiaNorbert Schmitz, Meral Beksac, Dirk Hasenclever, et al.
British Journal of Haematology|May 26, 2020
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studiesRégis Peffault de Latour, Robert A Brodsky, Stephan Ortiz, et al.
Pageof 15